View in EDS

Identifying immune-related predictive factors for post-eribulin therapy in patients with HER2-negative advanced breast cancer- a multicenter retrospective study.

Saved in:
Bibliographic Details
Title: Identifying immune-related predictive factors for post-eribulin therapy in patients with HER2-negative advanced breast cancer- a multicenter retrospective study.
Authors: Takamatsu Y; Department of Breast Oncology, Faculty of Medicine, Juntendo University, Tokyo, Japan., Horimoto Y; Department of Breast Oncology, Faculty of Medicine, Juntendo University, Tokyo, Japan.; Department of Breast Surgery and Oncology, Tokyo Medical University, Tokyo, Japan., Miyoshi Y; Department of Surgery, Division of Breast and Endocrine Surgery, School of Medicine, Hyogo Medical University, Nishinomiya, Japan., Watanabe J; Department of Breast Oncology, Faculty of Medicine, Juntendo University, Tokyo, Japan. j.watanabe.vq@juntendo.ac.jp.; Department of Breast Oncology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo, 113-0033, Japan. j.watanabe.vq@juntendo.ac.jp., Kutomi G; Department of Breast Oncology, Faculty of Medicine, Juntendo University, Tokyo, Japan.; Department of Breast Oncology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo, 113-0033, Japan.
Source: International journal of clinical oncology [Int J Clin Oncol] 2026 Apr; Vol. 31 (4), pp. 658-665. Date of Electronic Publication: 2026 Jan 31.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1437-7772
DOI:10.1007/s10147-026-02977-5